Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
Spigel DR, Dowlati A, Chen Y, Navarro A, Yang JC, Stojanovic G, Jove M, Rich P, Andric ZG, Wu YL, Rudin CM, Chen H, Zhang L, Yeung S, Benzaghou F, Paz-Ares L, Bunn PA; RESILIENT Trial Investigators. Spigel DR, et al. J Clin Oncol. 2024 Apr 22:JCO2302110. doi: 10.1200/JCO.23.02110. Online ahead of print. J Clin Oncol. 2024. PMID: 38648575
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
Patel JS, Woo Y, Draper A, Jansen CS, Carlisle JW, Innominato PF, Lévi FA, Dhabaan L, Master VA, Bilen MA, Khan MK, Lowe MC, Kissick H, Buchwald ZS, Qian DC. Patel JS, et al. Among authors: carlisle jw. J Immunother Cancer. 2024 Mar 26;12(3):e008011. doi: 10.1136/jitc-2023-008011. J Immunother Cancer. 2024. PMID: 38531662 Free PMC article.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour G, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville JC, Grey A, Grohmann S, Gurrin L, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O'Connell NE, Parker L, Redman BK, Seidler L, Sheldrick KA, Sydenham E, Torgerson D, van Wely M, Wang R, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: carlisle j. BMJ Open. 2024 Mar 11;14(3):e084164. doi: 10.1136/bmjopen-2024-084164. BMJ Open. 2024. PMID: 38471680 Free PMC article.
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer.
Valanparambil RM, Lai L, Johns MA, Davis-Gardner M, Linderman SL, McPherson TO, Chang A, Akhtar A, Gamarra ELB, Matia H, McCook-Veal AA, Switchenko J, Nasti TH, Green F, Saini M, Wieland A, Pinsky BA, Solis D, Dhodapkar MV, Carlisle J, Ramalingam S, Ahmed R, Suthar MS. Valanparambil RM, et al. Among authors: carlisle j. NPJ Vaccines. 2023 Nov 21;8(1):179. doi: 10.1038/s41541-023-00779-8. NPJ Vaccines. 2023. PMID: 37990024 Free PMC article.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour V, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville J, Grey A, Grohmann S, Gurrin LC, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O' Connell NE, Parker L, Redman BK, Seidler AL, Sheldrick KA, Sydenham E, Torgerson DJ, van Wely M, Wang R, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: carlisle j. medRxiv [Preprint]. 2023 Nov 13:2023.09.21.23295626. doi: 10.1101/2023.09.21.23295626. medRxiv. 2023. PMID: 37873409 Free PMC article. Updated. Preprint.
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP; LCMC study investigators. Chaft JE, et al. Nat Med. 2024 Jan;30(1):303. doi: 10.1038/s41591-023-02627-7. Nat Med. 2024. PMID: 37816821 Free PMC article. No abstract available.
Characteristics and anatomic location of PD-1+TCF1+ stem-like CD8 T cells in chronic viral infection and cancer.
Im SJ, Obeng RC, Nasti TH, McManus D, Kamphorst AO, Gunisetty S, Prokhnevska N, Carlisle JW, Yu K, Sica GL, Cardozo LE, Gonçalves ANA, Kissick HT, Nakaya HI, Ramalingam SS, Ahmed R. Im SJ, et al. Among authors: carlisle jw. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2221985120. doi: 10.1073/pnas.2221985120. Epub 2023 Oct 2. Proc Natl Acad Sci U S A. 2023. PMID: 37782797 Free PMC article.
283 results